TEST BANK For Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics, 8th Edition by Nader Rifai, Verified Chapters 1 - 49, Complete Newest Version

Test bank for Tietz Fundamentals of Clinical Chemistr
and Molecular Diagnostics,
8th Edition by Nader Rifai, PhD
Chapters 1 - 49

,Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics 8th Edition Test Bank
kd kd kd kd kd kd kd kd
kd
kd kd




Table of contents:kd kd




I. Principles Of Laboratory Medicine
kd kd kd kd




Chapter 1. Clinical Chemistry, Molecular Diagnostics, and Laboratory Medicine
kd kd kd kd kd kd kd kd




Chapter 2. Selection and Analytical Evaluation of Methods — With Statistical Techniques
kd kd kd kd kd kd kd kd kd kd kd




Chapter 3. Clinical Evaluation of Methods
kd kd kd kd kd




Chapter 4. Evidence-Based Laboratory Medicine
kd kd kd kd




Chapter 5. Establishment and Use of Reference Values
kd kd kd kd kd kd kd




Chapter 6. Specimen Collection, Processing, and Other Preanalytical Variables
kd kd kd kd kd kd kd kd




Chapter 7. Quality Management
kd kd kd




II. Analytical Techniques And Instrumentation
kd kd kd kd




Chapter 8. Principles of Basic Techniques and Laboratory Safety
kd kd kd kd kd kd kd kd




Chapter 9. Optical Techniques
kd kd kd




Chapter 10. Electrochemistry and Chemical Sensors
kd kd kd kd kd




Chapter 11. Electrophoresis
kd kd




Chapter 12. Chromatography
kd kd




Chapter 13. Mass Spectrometry
kd kd kd




Chapter 14. Enzyme and Rate Analyses
kd kd kd kd kd




Chapter 15. Immunochemical Techniques
kd kd kd




Chapter 16 Automation kd kd




Chapter 17. Point-of-Care Instrumentation
kd kd kd




III. Analytes
k d




Chapter 18. Amino Acids, Peptides, and Proteins
kd kd kd kd kd kd




Chapter 19. Serum Enzymes
kd kd kd




Chapter 20. Tumor Markers and Cancer Genes
kd kd kd kd kd kd




Chapter 21. Kidney Function Tests — Creatinine, GFR, Urea, and Uric Acid
kd kd kd kd kd kd kd kd kd kd kd




Chapter 22. Carbohydrates
kd kd




Chapter 23. Lipids, Lipoproteins, Apolipoproteins, and Other Cardiac Risk Factors
kd kd kd kd kd kd kd kd kd




Chapter 24. Electrolytes and Blood Gases
kd kd kd kd kd




Chapter 25. Hormones kd kd




Chapter 26. Catecholamines and Serotonin
kd k d kd kd




Chapter 27. Vitamins, Trace Elements, Nutritional Assessment
kd k d kd kd kd kd




Chapter 28. Hemoglobin, Iron, and Bilirubin
kd kd kd kd kd




Chapter 29. Porphyrins and Porphyrias
kd kd kd kd




Chapter 30. Therapeutic Drugs and Their Management
kd kd kd kd kd kd




Chapter 31. Clinical Toxicology
kd kd kd




Chapter 32. Toxic Metals
kd k d kd




IV. Pathophysiology
k d




Chapter 33. Diabetes kd kd

,Chapter 34. Cardiovascular Disease
kd k d kd




Chapter 35. Kidney Disease
kd kd kd




Chapter 36. Physiology and Disorders of Water, Electrolyte, and Acid-Base Metabolism
kd k d kd kd kd kd kd kd kd kd




Chapter 37. Liver Disease
kd kdkd kd




Chapter 38. Gastrointestinal and Pancreatic Diseases
kd k d kd kd kd




Chapter 39. Disorders of Bone and Mineral Metabolism
kd kdkd kd kd kd kd kd




Chapter 40. Disorders of the Pituitary Gland
kd kdkd kd kd kd kd




Chapter 41. Disorders of the Adrenal Cortex
kd k d kd kd kd kd




Chapter 42. Thyroid Disorders
kd k d kd




Chapter 43. Reproduction-Related Disorders
kd k d kd




Chapter 44. Pregnancy and Prenatal Testing
kd kdkd kd kd kd




Chapter 45. Newborn Screening and Inborn Errors of Metabolism
kd k d kd kd kd kd kd kd




Chapter 46. Pharmacogenetics
kd kd




V. Molecular Diagnostics
k d kd




Chapter 47. Principles of Molecular Biology
kd kd kd kd kd




Chapter 48. Nucleic Acid Techniques and Applications
kd kd kd kd kd kd




Chapter 49. Genomes and Nucleic Acid Alterations
kd kd kd kd kd kd

, Chapter 01: Clinical Chemistry, Molecular Diagnostics, and Laboratory Medicine TestBan
kd kd kd kd kd kd kd kd kd kd



k


MULTIPLE CHOICE kd




1. An individual working in a clinical chemistry laboratory is married to a sales representative
kd kd kd kd kd kd kd kd kd kd kd kd kd kd



who works for a company that sells chemistry laboratory supplies. When the laboratory m
kd kd kd kd kd kd kd kd kd kd kd kd kd



anager requests a list of needed supplies, cost of supplies, and vendors, this individual only
kd kd kd kd kd kd kd kd kd kd kd kd kd kd d
k



recommends the spouse’s company as the vendor. This is considered to be a(n): kd kd kd kd kd kd kd kd kd kd kd kd



a. accounting issue. kd



b. possible conflict of interest. kd kd kd



c. maintenance of confidentiality issue. kd kd kd



d. problem with resource allocation. kd kd kd




ANS: B kd



Concern has been raised over the interrelationships between practitioners in the medical fi
kd kd kd kd kd kd kd kd kd kd kd kd



eldand commercial suppliers of drugs, devices, equipment, etc., to the medical profession.
d
k kd kd kd kd kd kd kd kd kd kd kd



Similarly, relationships have been scrutinized between clinical laboratorians and manufactur
kd kd kd kd kd kd kd kd kd



ers and providers of diagnostic equipment and supplies. These concerns led the National Ins
kd kd kd kd kd kd kd kd kd kd kd kd kd



titutes of Health (NIH) in 1995 to require official institutional review of financial disclosure b
kd kd kd kd kd kd kd kd kd kd kd kd kd kd



y researchers and management of situations in which disclosure indicates potentialconflicts
kd kd kd kd kd kd kd kd kd kd d
k kd



of interest.
kd




DIF: 1 REF: Page 4-5 kdkdkd kd OBJ: 6 | 7 kd kd kd




2. A patient visits her physician stating that her prescribed painkiller is not working to reduc
kd kd kd kd kd kd kd kd kd kd kd kd kd kd



e the pain following her recent surgery. A friend of the patient claims that the same paink
kd kd kd kd kd kd kd kd kd kd kd kd kd kd kd kd



iller“worked wonders” to reduce her pain after the same surgery. The physician states th
d
k kd kd kd kd kd kd kd kd kd kd kd kd kd



at the difference in the effect of the drug might be caused by
kd kd kd kd kd kd kd kd kd kd kd kd



, which is studied in pharmacogenetics.
kd kd kd kd kd



a. epidemiology
b. an inherited disease kd kd



c. a conflict of interest kd kd kd



d. a genetic variation in drug-metabolizing enzymes
kd kd kd kd kd




ANS: D kd



Pharmacogenetics is the study of the genetic variation of drug metabolism betwe kd kd kd kd kd kd kd kd kd kd kd



enindividuals.
d
k




DIF: 1 REF: Page 3 kdkdkd kd OBJ: 1 kd




3. John works in a molecular diagnostics laboratory and receives a blood sample that has th
kd kd kd kd kd kd kd kd kd kd kd kd kd kd



e name of a close friend printed on the bar-
kd kd kd kd kd kd kd kd kd



coded label. The genetic test that is ordered on thefriend’s sample would provide diagnos
kd kd kd kd kd kd kd kd kd d
k kd kd kd kd



tic information about a disorder that has a poor prognosis, and the test is usually perfor
kd kd kd kd kd kd kd kd kd kd kd kd kd kd kd



med by John. He asks a fellow employee to analyzethe sample for him and not divulge th
kd kd kd kd kd kd kd kd kd d
k kd kd kd kd kd kd kd



e results. This ethical issue concerns:
kd kd kd kd kd



a. confidentiality of patient genetic and medical information. kd kd kd kd kd kd



b. a conflict of interest.kd kd kd



c. resource allocation. kd



d. diagnostic accuracy. kd